0001731122-24-000425.txt : 20240313
0001731122-24-000425.hdr.sgml : 20240313
20240313155048
ACCESSION NUMBER: 0001731122-24-000425
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarsh Simon
CENTRAL INDEX KEY: 0001943931
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38758
FILM NUMBER: 24745852
MAIL ADDRESS:
STREET 1: 201 E. FIFTH STREET SUITE 1900
CITY: CINCINNATI
STATE: OH
ZIP: 45202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RENOVARO INC.
CENTRAL INDEX KEY: 0001527728
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452259340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 45 39179840
MAIL ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC.
DATE OF NAME CHANGE: 20230807
FORMER COMPANY:
FORMER CONFORMED NAME: Enochian Biosciences Inc.
DATE OF NAME CHANGE: 20230804
FORMER COMPANY:
FORMER CONFORMED NAME: Renovaro Biosciences Inc.
DATE OF NAME CHANGE: 20230802
4
1
ownership.xml
X0508
4
2024-03-11
0
0001527728
RENOVARO INC.
RENB
0001943931
Tarsh Simon
C/O RENOVARO INC.
2080 CENTURY PARK E, SUITE 906
LOS ANGELES
CA
90067
0
1
0
0
Interim CFO
0
Option to purchase shares of common stock
2.98
2024-03-11
4
A
0
10000
0
A
2034-03-11
Common Stock
10000
10000
D
This option vests upon the termination of the Consulting Agreement effective March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date.
/s/ Simon Tarsh
2024-03-13